Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
10/26/10	€0.1578	0.00%	1,29,171
07/26/07	€0.1578	-0.75%	1,51,178
06/26/06	€0.1590	+1.27%	83,826
05/26/05	€0.1570	-1.13%	99,467
04/26/04	€0.1588	+0.63%	95,428

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Euronext Paris Other stock markets 03:22:43 10/08/2026 pm IST			5-day change	1st Jan Change
0.1578 ^EUR	0.00%		0.00%	-27.95%

29/07	EQT to sell Quantios to Vista Equity Partners	FW
15/07	Klea Holding targets improved profitability in the second half

Market Cap	4.84Cr 5.6Cr 4.52Cr 4.15Cr 7.81Cr 532.99Cr 7.93Cr 53Cr 21Cr 267.15Cr 21Cr 21Cr 883.18Cr	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	4.86Cr 5.61Cr 4.54Cr 4.16Cr 7.83Cr 534.37Cr 7.95Cr 53Cr 21Cr 267.84Cr 21Cr 21Cr 885.46Cr	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

29/07	EQT to sell Quantios to Vista Equity Partners	FW
15/07	Klea Holding targets improved profitability in the second half
11/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
11/06	Klea Holding announces the launch of its new subsidiary
23/04	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/04	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
01/04	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
19/01	Klea Holding Increases Annual Revenue by 28%
19/01	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
19/01	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/25/27	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/25/27	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT

15/07	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
15/07	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
11/06	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
23/04	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
23/04	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

Klea Holding Share Price

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

27/07	Klea Holding : Déclaration des transactions sur actions propres
20/07	Klea Holding : Déclaration des transactions sur actions propres
15/07	Klea Holding vise une amélioration de sa rentabilité au second semestre
15/07	Klea Holding : Smart Salem enregistre un puissant rebond de son activité en juin 2026, confirme sa solide rentabilité et ses perspectives favorables
13/07	Klea Holding : Déclaration des transactions sur actions propres

Current month	+1.02%
1 month	-10.54%
3 months	-17.55%
6 months	-28.27%
Current year	-27.95%

1 week	0.16	0.16
1 month	0.16	0.18
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.48
5 years	0.08	0.59
10 years	0.08	149.6

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Date	Insider	Type	Quantity	% Market Cap.
17/07/26	Raphael Smila	Buy	1,03,000	0.0335%
17/07/26	Raphael Smila	Buy	1,03,000	0.0335%
16/07/26	Raphael Smila	Buy	87,000	0.0283%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	0.00%	0.00%	-19.82%	-66.64%	5.6Cr
CVS HEALTH CORPORATION	-0.54%	-8.36%	+46.02%	+28.28%	12TCr
HCA HEALTHCARE, INC.	+1.09%	+2.68%	+8.32%	+54.76%	8.95TCr
FRESENIUS SE & CO. KGAA	-0.63%	+4.58%	+6.89%	+56.80%	3.06TCr
QUEST DIAGNOSTICS INCORPORATED	-0.06%	+2.29%	+34.69%	+76.11%	2.63TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	-2.31%	-11.93%	-12.79%	2.17TCr
TENET HEALTHCARE CORPORATION	+2.14%	+2.88%	+58.31%	+258.20%	2.11TCr
REDE D'OR SÃO LUIZ S.A.	-0.41%	-2.08%	-6.48%	-0.06%	1.46TCr
FRESENIUS MEDICAL CARE AG	+0.10%	-6.17%	+1.52%	-12.18%	1.29TCr
DAVITA INC.	+1.72%	-23.46%	+41.91%	+67.12%	1.17TCr
Average	+0.40%	-2.57%	+15.94%	+44.96%	3.51TCr
Weighted average by Cap.	+0.39%	-2.52%	+25.33%	+51.02%

	2024	2025
Net sales	1.73Cr 2Cr 1.61Cr 1.48Cr 2.78Cr 189.9Cr 2.83Cr 19Cr 7.42Cr 95Cr 7.49Cr 7.33Cr 314.67Cr	2.22Cr 2.56Cr 2.07Cr 1.9Cr 3.57Cr 243.88Cr 3.63Cr 24Cr 9.53Cr 122.24Cr 9.62Cr 9.41Cr 404.12Cr
Net income	14.05L 16.24L 13.12L 12.04L 22.64L 15Cr 23L 1.54Cr 60.42L 7.75Cr 60.99L 59.66L 26Cr	22.81L 26.37L 21.3L 19.54L 36.75L 25Cr 37.34L 2.5Cr 98.09L 13Cr 99.02L 96.86L 42Cr
Net Debt	25.75L 29.77L 24.05L 22.06L 41.49L 28Cr 42.15L 2.82Cr 1.11Cr 14Cr 1.12Cr 1.09Cr 47Cr	1L 1L 1L 1L 2L 1.38Cr 2L 13.7L 5L 68.93L 5L 5L 2.28Cr